Isomab Ltd
Founded 2022
Nottingham, United Kingdom
15 employees
Seed
Total: $7.50M
Nottingham, United Kingdom
15 employees
Seed
Total: $7.50M
General Information
Company Name
Isomab Ltd
Founded Year
2022
Location
Nottingham, United Kingdom
Nottingham, United Kingdom
Employees
15
Funding Stage
Seed
BounceWatch is an independent company data service, not affiliated with Isomab Ltd. To contact Isomab Ltd, visit isomab.bio.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
United Kingdom Market
About Isomab Ltd
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Seed Round | £7.50M | 3 |
|
20 Feb 2024 |
| Pre Seed Round | Undisclosed | 1 |
|
01 Jan 2023 |
Latest News
View All
FAQ About Isomab Ltd
IsomAb is taking a different approach to identify, evaluate and develop isoform specific antibodies to treat disease where patients currently have limited or no treatment options.
IsomAb is developing isoform specific antibodies and it has identified, using a combined bioinformatics/knowledge-based...
Isomab Ltd was founded in 2022.
Isomab Ltd is headquartered in Nottingham, United Kingdom.
Isomab Ltd has approximately 15 employees.
Isomab Ltd has completed 2 funding rounds, raising a total of $7.50M. The latest funding stage is Seed.
Source: BounceWatch company record for Isomab Ltd, https://bouncewatch.com/company/isomab, updated 30 December 2024. When citing, please name BounceWatch and link this page.
